Latest Press Releases

Reconnecting to Ancient Practices: The Role of Medical Intuitives in Holistic Health

In today's fast-paced world, where holistic health and alternative therapies are gaining traction, the Medical Intuitive Directory is emerging as an essential resource for individuals seeking an integrated approach to health and wellness. ...

What You Need to Know About Delta 8 Gummies and How They Compare to HHC Gummies

In the ever-expanding world of cannabis products, Delta 8 THC and HHC (Hexahydrocannabinol) gummies have emerged as popular alternatives to traditional Delta 9 THC, the primary psychoactive compound found in marijuana. While both Delta 8 and ...

What Are CBD Gummies & Should I Take Them?

CBD gummies have exploded in popularity as a natural way to experience the benefits of cannabidiol (CBD) without the need for vaping, smoking, or using tinctures. As an edible form of CBD, these gummies provide a tasty, convenient, and ...

Everything You Need To Know About Disposable Vapes

Disposable vapes have gained immense popularity over the last few years as a convenient alternative to traditional smoking and vaping devices. With sleek designs, various flavors, and easy accessibility, they have become the go-to choice for ...

How THC Gummies Impact Your Health

THC (tetrahydrocannabinol) gummies have become a popular way for many people to experience the effects of cannabis, especially as laws around marijuana become more relaxed. Unlike smoking or vaping, THC gummies offer a discreet and often more ...

Boehringer Ingelheim Partners with NCD Alliance to Target Non-Communicable Diseases in Underserved Communities

Boehringer Ingelheim has entered a partnership with the NCD Alliance, a network dedicated to shaping a world in which everyone can live a healthy and productive life, free from the preventable suffering, stigma, disability, and death caused by ...

Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clinical studies, MNV-201 demonstrated improved engraftment and bone marrow reconstitution potential ...

Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease

PR Newswire CARLSBAD, Calif., Oct. 1, 2024 CARLSBAD, Calif., Oct. 1, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has granted zilganersen Fast Track ...

Revolutionary lab-grown lung tissue set to transform therapies for respiratory diseases and organ transplantation

PR Newswire HAYWARD, Calif., Oct. 1, 2024 HAYWARD, Calif., Oct. 1, 2024 /PRNewswire/ -- Frontier Bio Corporation today announced a groundbreaking achievement in lab-grown lung tissue. By combining 3D bioprinting with the ability of stem ...

Nuna Proudly Partners with Susan G. Komen® in Support of the Breast Cancer Community

PR Newswire PORTLAND, Ore., Oct. 1, 2024 The Parent-Loved Brand is Proud to Join the Fight Against Breast Cancer and Launch the Thistle Collection in Honor of National Breast Cancer Awareness Month PORTLAND, Ore., Oct. 1, 2024 ...

Bubble Bud Inc. Urges Health Canada to Act on Cannabis Beverage Testing Deficiencies

Canada NewsWire EDMONTON, AB, Oct. 1, 2024 EDMONTON, AB, Oct. 1, 2024 /CNW/ - Bubble Bud Inc., a leading innovator in the cannabis-infused beverage sector, is calling for Health Canada to take immediate action to address critical flaws in ...

Resolution Therapeutics Announces Upcoming Presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2024

PR Newswire EDINBURGH, Scotland and LONDON, Oct. 1, 2024 – Oral Presentation of complete data from the three-year MATCH Phase 2 trial – Poster Presentation demonstrating preclinical proof of concept of safety and efficacy of RTX001, an ...

World Urticaria Day: Understanding and Supporting Those Affected

Canada NewsWire QUEBEC CITY, Oct. 1, 2024 QUEBEC CITY, Oct. 1, 2024 /CNW/ - Every year, on October 1st, is World Urticaria Day, a day dedicated to raising awareness about urticaria, commonly known as hives. This condition affects a ...

Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia

PR Newswire BUFFALO, N.Y., Sept. 30, 2024 The Clinical Leukemia Service at Roswell Park Comprehensive Cancer Center helped lead the first clinical trial of the experimental oral drug ziftomenib in patients with acute myeloid leukemia (AML). ...

New Research Reveals Positive Associations Between Online Content Creators and Community Connection for LGBTQ+ Young People

PR Newswire SAN FRANCISCO, Sept. 30, 2024 SAN FRANCISCO, Sept. 30, 2024 /PRNewswire/ -- New research from Hopelab, in collaboration with media psychology expert Dr. Bradley Bond, sheds light on the powerful role that social media and ...

Neurocrine Biosciences's Crinecerfont is Set to Transform the Congenital Adrenal Hyperplasia Treatment Market | DelveInsight

PR Newswire LAS VEGAS, Sept. 30, 2024 Neurocrine Biosciences has announced that the US Food and Drug Administration (FDA) has accepted its two New Drug Applications (NDA) for crinecerfont, granting them Priority Review designations. The ...

Cardiology Profile: Memorial Cardiac and Vascular Institute's Alvaro Vargas Pelaez

PR Newswire HOLLYWOOD, Fla., Sept. 30, 2024 Dr. Alvaro Vargas Pelaez is a board-certified cardiologist with Memorial Cardiac and Vascular Institute. HOLLYWOOD, Fla., Sept. 30, 2024 /PRNewswire-PRWeb/ -- Dr. Alvaro Vargas Pelaez is a ...

New Shatterproof National Poll: Majority of U.S. Adults Misunderstand and Hold Negative Perceptions of People with Substance Use Disorders

PR Newswire NORWALK, Conn., Sept. 30, 2024 Majority of adults (74%) don't believe a person with a substance use disorder (SUD) is experiencing a chronic medical illness. Read the full results. NORWALK, Conn., Sept. 30, 2024 /PRNewswire/ ...

PPMW raises $144,000 for abortion access in 15 minutes at Impact Gala

PR Newswire WASHINGTON, Sept. 30, 2024 WASHINGTON, Sept. 30, 2024 /PRNewswire/ -- Nearly 500 guests gathered at the Impact Gala hosted by Planned Parenthood of Metropolitan Washington, DC (PPMW) on Saturday, September 28, 2024, where ...

Johnson & Johnson files for U.S. FDA approval of DARZALEX FASPRO®-based quadruplet regimen for newly diagnosed multiple myeloma patients for whom transplant is not planned

PR Newswire RARITAN, N.J., Sept. 30, 2024 Results from CEPHEUS study highlight DARZALEX FASPRO® quadruplet regimen as a potential standard of care in newly diagnosed patients regardless of transplant eligibility New indication would be ...

The Halpern Law Firm is Proud to Announce a Number of Large Settlements for Clients, Serving Justice to Victims of Asbestos Exposure

PR Newswire ARDMORE, Pa. and PITTSBURGH, Sept. 30, 2024 ARDMORE, Pa. and PITTSBURGH, Sept. 30, 2024 /PRNewswire/ -- The Halpern Law Firm proudly announces a series of substantial settlements recently secured on behalf of victims of ...

Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination

PR Newswire WALTHAM, Mass. and SAN DIEGO, Sept. 30, 2024 Head-to-head data, presented at OPTIONS XII for the Control of Influenza Conference, demonstrates advantage of sa-mRNA over conventional mRNA in duration of immune response; Results ...

Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine

PR Newswire NEW HAVEN, Conn., Sept. 30, 2024 NEW HAVEN, Conn., Sept. 30, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and ...

Reconnecting to Ancient Practices: The Role of Medical Intuitives in Holistic Health

In today's fast-paced world, where holistic health and alternative therapies are gaining traction, the Medical Intuitive Directory is emerging as an essential resource for individuals seeking an integrated approach to health and wellness. ...

ISCT Becomes the First Cell and Gene Therapy Organization to Achieve ANAB Accreditation for Workforce Development

PR Newswire VANCOUVER, BC, Sept. 30, 2024 VANCOUVER, BC, Sept. 30, 2024 /PRNewswire/ - The ISCT Institute of Training & Development, a division of the International Society for Cell and Gene Therapy (ISCT), has become the first cell and gene ...

Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients

PR Newswire CAMBRIDGE, Mass., Sept. 30, 2024 CAMBRIDGE, Mass., Sept. 30, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced ...

RedHill Announces New U.S. Coronavirus Patent for Opaganib, Valid Through 2041

PR Newswire TEL-AVIV, Israel and RALEIGH, N.C., Sept. 30, 2024 New U.S. patent issued covering the identification of a novel biomarker of coronavirus pneumonia (=60% fraction of inspired oxygen (FiO2)) prognostic for potential opaganib ...

UCB Announces a Head-to-Head Study Evaluating BIMZELX® (bimekizumab) versus SKYRIZI® (risankizumab) in Active Psoriatic Arthritis

PR Newswire ATLANTA, Sept. 30, 2024 ATLANTA, Sept. 30, 2024 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin ...

NUS researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics

PR Newswire SINGAPORE, Sept. 30, 2024 Scalable and adaptable, TETRIS captures the diversity of protein interactions on site to inform accurate cancer diagnoses, enabling the personalisation of ensuing treatments. SINGAPORE, Sept. 30, ...

Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Severe Hypertriglyceridemia

PR Newswire HANGZHOU, China, Sept. 30, 2024 HANGZHOU, China, Sept. 30, 2024 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic ...

Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting

PR Newswire OSLO, Norway, Sept. 30, 2024 OSLO, Norway, Sept. 30, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated that international ...

IASO Bio Scientist and Leading Chinese Physicians in Onco-Hematology Visit Hematology Center at the State University of Campinas, Brazil, to Explore Cooperation in Cancer Treatment

PR Newswire SHANGHAI and NANJING, China and SAN JOSE, Calif., Sept. 30, 2024 SHANGHAI and NANJING, China and SAN JOSE, Calif., Sept. 30, 2024 /PRNewswire/ -- On September 23, in Rio de Janeiro, on the eve of the International Myeloma Society ...

Akeso's Cadonilimab Receives Second Indication Approval from NMPA for First-Line Treatment of Gastric/GEJ Cancer in All-Comers Population

PR Newswire HONG KONG, Sept. 30, 2024 HONG KONG, Sept. 30, 2024 /PRNewswire/ -- September 30, 2024, Akeso (9926. HK) announced that its internally developed PD-1/CTLA-4 bispecific antibody, cadonilimab, has received approval from the ...

What You Need to Know About Delta 8 Gummies and How They Compare to HHC Gummies

In the ever-expanding world of cannabis products, Delta 8 THC and HHC (Hexahydrocannabinol) gummies have emerged as popular alternatives to traditional Delta 9 THC, the primary psychoactive compound found in marijuana. While both Delta 8 and ...

What Are CBD Gummies & Should I Take Them?

CBD gummies have exploded in popularity as a natural way to experience the benefits of cannabidiol (CBD) without the need for vaping, smoking, or using tinctures. As an edible form of CBD, these gummies provide a tasty, convenient, and ...

World's First Carbon Neutral Salad: The Revolutionary Drinkable Salad that's Good for You and the Planet

PR Newswire HONG KONG, Sept. 29, 2024 HONG KONG, Sept. 29, 2024 /PRNewswire/ -- Tired of sacrificing taste for nutrition? Try Future Salad, the world's first carbon-neutral drinkable salad. It supports a healthy lifestyle and combats climate ...

Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of next-generation CDK inhibitors for the Treatment of Breast Cancer

PR Newswire CAMBRIDGE, Mass., Sept. 30, 2024 CAMBRIDGE, Mass., Sept. 30, 2024 /PRNewswire/ -- Regor Pharmaceuticals (USA) ("Regor") has entered into a definitive purchase agreement whereby Genentech, a member of the Roche Group, will acquire ...

Latest Press Releases

Premium Press Releases »

Press Releases »

Medindia Newsletters

Latest Press Releases

Follow Us On :